Bacterial Magnetosome Chains for Hyperthermia Heating Capacity
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current cancer therapies using chemically synthesized magnetic nanoparticles for hyperthermia face challenges due to toxicity concerns and the need for higher heating capacity to minimize nanoparticle quantity, while bacterial magnetosomes have shown promise but require optimization for effective in vivo heat treatment.
Innovation Solution
Chains of magnetosomes extracted from magnetotactic bacteria, cultivated under specific conditions with additives like transition metals and chelating agents, are used to generate heat in situ when exposed to an alternating magnetic field, either alone or encapsulated in lipid vesicles, to enhance heating efficiency and reduce toxicity.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Temperature
If chemically synthesized magnetic nanoparticles are used for hyperthermia, then heating capacity is achieved, but toxicity concerns arise
Solution Approach 1:
The patent uses bacterial magnetosomes as disposable heating agents that can be administered, used for hyperthermia treatment, and then eliminated from the body. The magnetosomes serve their heating function and are subsequently cleared by the body's natural elimination processes, avoiding long-term toxicity accumulation
Solution Approach 2:
The patent employs magnetosomes as intermediary agents that convert magnetic field energy into heat locally at the tumor site. These magnetosomes act as mediators between the external alternating magnetic field and the tumor tissue, enabling targeted heating without direct thermal contact or systemic toxic effects
2Temperature
If larger quantity of magnetic nanoparticles is used to achieve sufficient heating, then heating capacity increases, but toxicity and side effects increase
Solution Approach 1:
The patent optimizes the magnetic properties of magnetosomes by controlling bacterial cultivation conditions, including iron availability and growth parameters. This enhances the specific absorption rate (SAR) of the magnetosomes, allowing sufficient heating capacity with reduced nanoparticle quantities
Solution Approach 2:
The patent uses magnetosomes composed of magnetite or maghemite with specific crystal structures and magnetic properties. These composite magnetic materials exhibit high heating efficiency per unit mass, reducing the total quantity needed for effective hyperthermia treatment
3Object-affected harmful factors
If bacterial magnetosomes are used instead of chemically synthesized nanoparticles, then toxicity is reduced, but heating efficiency requires optimization
Solution Approach 1:
The patent systematically optimizes magnetosome heating efficiency by adjusting bacterial cultivation parameters, including iron concentration in growth medium, temperature, pH, and aeration conditions. These parameter changes enhance the magnetic moment and heating performance of the magnetosomes while maintaining their biocompatibility
Solution Approach 2:
The patent demonstrates that magnetosomes produced under different cultivation conditions can all serve the hyperthermia function, providing a versatile platform for producing heating-efficient magnetosomes with reduced toxicity. The universal applicability of the bacterial production system allows optimization without compromising safety
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The use of chains of magnetosomes achieves higher heating capacity and improved anti-tumoral activity, with enhanced heat production and reduced toxicity, allowing for effective in vivo destruction of tumor cells through hyperthermia or thermoablation.
Implementation Method 1
The heat is generated by chains of bacterial magnetosomes, which are extracted from magnetotactic bacteria... when an oscillating magnetic field is applied to them
Implementation Method 2
the heat has been induced using chemically synthesized nanoparticles, mainly in the form superparamagnetic iron oxide nanoparticles (SPION)... alternating magnetic field (AMF) hyperthermia
Data Source
AI summary
A method for the treatment of tumor(s) or tumor cell(s) or cancer(s) in a subject in need by the generation of heat. The latter is produced by chains of magnetosomes extracted from whole magnetotactic bacteria and subjected to an alternating magnetic field. These chains of magnetosomes yield efficient antitumoral activity whereas magnetosomes unbound from the chains or kept within the whole bacteria produce poor or no antitumoral activity. The introduction of various chemicals such as chelating agents and/or transition metals within the growth medium of the bacteria improves the heating properties of the chains of magnetosomes. Moreover, the insertion of the chains of magnetosomes within a lipid vesicle is also suggested in order to favor their rotation in vivo and hence to improve their heating capacity. The vesicle can contain an antitumoral agent together with the chains of magnetosomes. In this case, the agent is released within the tumors by heating the vesicle.